Filing Details

Accession Number:
0001078782-20-000367
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-22 16:27:46
Reporting Period:
2020-05-22
Accepted Time:
2020-05-22 16:27:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1340610 John Cameron Reynolds 13215 Bee Cave Parkway
Suite 125 Galleria Oaks B
Austin TX 78738
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-22 4,000 $2.75 1,126,273 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 34,076 Indirect By Wife
Common Stock 1,007,718 Indirect Concord International, Inc.
Footnotes
  1. The shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on May 22, 2020. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriter.
  2. The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.